PMCTPharmaCountry
    Home
    No categories for this tab
About Us
  • About PharmaCountry
  • How It Works
  • Partnerships
  • Sustainability
  • Contact Us
For Buyers
  • Search Products
  • Search Services
  • Find Suppliers
  • Find Jobs
  • Find Seekers
  • Help Center
  • FAQ
  • Buyer Protection
For Sellers/Service Providers
  • Start Selling
  • Seller Guide
  • Pricing Plans
  • Advertising
  • Seller Support
Top Categories
  • Active Pharmaceutical Ingredients (APIs)
  • Finished Dosage Forms
  • Manufacturing Equipment & Utilities
  • Excipients & Additives
  • View All Categories
Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform
SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network
PMCTPharmaCountry
© 2026 PharmaCountry. All rights reserved.
Privacy PolicyTerms of ServiceCookie Policy
  1. Products
  2. Finished Dosage Forms
  3. Tablets
  4. Immediate-Release Tablets

Erlotinib Tablets 100 mg

RG
RV Group (S) Pte Ltd
Marketing Authorization Holder · Finished Dosage FormsFlag of SGSingapore
Image 1

Basic Information

Category

Subcategory & Sub-subcategory

/

Trade Type

Sell

Product Name

Erlotinib Tablets 100 mg

Details

Substance

Manufacturer(s)

  • -

Registered Market

Specifications

  • Dosage Form: Tablet film-coated
  • Packaging: Box 3 blister x 10 tablet
  • Strength: 100mg
  • Standards: In-house standard
  • Shelf Life: 24 month

Documents

Drug Marketing Authorization Number
Document No.: 890114436225
Issue Date: Oct 19, 2025
Expiry Date: Oct 19, 2030
Note: 562/QĐ-QLD | 126

Ratings

(0)
(0)
(0)
(0)
(0)

Leave your rating & comment

Comments

Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More
Finished Dosage Forms
Tablets
Immediate-Release Tablets
Erlotinib hydrochloride 109,3 mg equivalent to Erlotinib
Erlotinib
M/s. Shilpa Medicare Limited
India
Viet Nam